News
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...
The test would help identify patients who may benefit from drugs that can modestly slow the memory-destroying disease.
Prostate cancer is the leading cause of cancer diagnosis in men in the U.S. and the second leading cause of cancer death, ...
The US Food and Drug Administration has cleared the first-ever blood test for diagnosing Alzheimer's disease, offering a less ...
The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s ...
Doctors stress the importance of early prostate cancer screenings, noting that while Biden's condition is incurable, early detection can lead to effective treatment.
Explore more
Stunned longtime aides to former President Joe Biden told The Post Monday that his stage 4 prostate cancer should have been ...
UVA Health’s Dr. Kirsten Greene explains why the aggressive disease may have been caught so late and what men should do to ...
Across the country, more than 180,000 men will be diagnosed with prostate cancer this year, and around 40,000 will die from ...
When caught early, prostate cancer is highly survivable, but it is also the second-leading cause of cancer death in men.
The FDA cleared the first blood test intended to help in diagnosing Alzheimer’s, marking a significant step in making diagnosis more accessible and less invasive. The test is designed for adults 55 ...
Former President Joe Biden's office announced on Sunday that he was diagnosed with an "aggressive" form of prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results